These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19138420)

  • 21. Current and potential treatments for primary biliary cholangitis.
    Shah RA; Kowdley KV
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):306-315. PubMed ID: 31806572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of cholestatic liver diseases.
    Paumgartner G
    J Dig Dis; 2010 Jun; 11(3):119-25. PubMed ID: 20579215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of ursodeoxycholic acid and chenodeoxycholic acid in Chinese medicinal compound preparations by TLC-densitometry].
    Zhang Z; Liao G; Song Y; Yin H
    Zhongguo Zhong Yao Za Zhi; 1995 Mar; 20(3):162-4, 192. PubMed ID: 7646779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AORTIC ANEURYSM, DISSECTION, AND RUPTURE IN SIX BILE-FARMED BEARS.
    Bando MKH; Nelson OL; Webster N; Ramsay JD; Bacon HJ; Sellon R
    J Zoo Wildl Med; 2018 Sep; 49(3):738-747. PubMed ID: 30212334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemical constituents of bear bile].
    Luo Q; Chen Q; Wu Y; Jiang M; Chen Z; Zhang X; Chen H
    Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2416-9. PubMed ID: 21141490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
    Clayton PT; Mills KA; Johnson AW; Barabino A; Marazzi MG
    Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research on artificial substitutes of rare and endangered animal medicinal materials and industrialization].
    Wu XC; Jia XB; Ma WK; Wu Q; Wang L; Yang B; Feng L
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6278-6286. PubMed ID: 36604872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of ursodeoxycholic acid in patients with liver disease.
    Angulo P
    Curr Gastroenterol Rep; 2002 Feb; 4(1):37-44. PubMed ID: 11825540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in studies on bear bile powder].
    Zhou CF; Gao GJ; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(7):1252-8. PubMed ID: 26281541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development history and prospect of Fel Ursi].
    Li XY; Su FF; Jiang C; Zhang W; Wang F; Zhu Q; Yang G
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4284-4291. PubMed ID: 36046854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid therapy versus placebo before and after extracorporeal shock wave lithotripsy of gallbladder stones. The East-Danish Gallstone Study Group.
    Aliment Pharmacol Ther; 1996 Aug; 10(4):651-7. PubMed ID: 8853772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of characteristic ions in frequently-used traditional Chinese medicinal materials derived from animal bile and its application].
    Shi Y; Xiong J; Wei F; Ma SC
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):651-658. PubMed ID: 29600636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol.
    Morton DH; Salen G; Batta AK; Shefer S; Tint GS; Belchis D; Shneider B; Puffenberger E; Bull L; Knisely AS
    Gastroenterology; 2000 Jul; 119(1):188-95. PubMed ID: 10889168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
    Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.
    Fischer S; Müller I; Zündt BZ; Jüngst C; Meyer G; Jüngst D
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):305-11. PubMed ID: 15195895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.